SEATTLE, WA--(Marketwire -03/09/12)- Plandaí Biotechnology, Inc. (OTC.BB: PLPL.OB - News) Chief Executive Officer Roger Duffield, today announced that a patent application has been filed on the company's proprietary process for increasing the absorption of plant phytonutrients, especially antioxidants. The document, which was filed with the U.S. Patent Office on February 14, 2012, covers the process of treating live plant material in a CRS Hydrodynamic Process in order to increase absorption by the body and to efficiently transport and release the phytonutrients into cells. The inventors are Dr. Tom Matula and Mr. Roger Duffield.
According to the literature, live plant materials subjected to the CRS hydrodynamic process releases the phytonutrients and, through the process, alters the stereochemical structure by changing trans-isomers into the cis form, and/or by changing cis-isomers into the trans form. Phytonutrients, such as carotenoids (found in tomatoes) usually have a 95% trans-structure, whereas flavonoids (such as those found in green tea) usually have a 95% cis-structure. The CRS hydrodynamic process alters the isomeric properties of released phytonutrients and rearranges them to a ratio more readily absorbable by human tissue, which ideally has a 50/50 cis/trans isomer ratio.
The benefits of delivering high concentrate bioavailable phytonutrients allows the body to more efficiently absorb the active and stable nutrients and antioxidants. For example, green tea, which is rich in antioxidants critical for protecting white and red blood cells and boosting the body's immune system, is not readily absorbed in its natural state. According to published research, the average person needs to consume 8-10 cups of green tea in order to receive a clinical dose of the necessary gallate catechins. Even the green tea extracts currently on the market lack the necessary bioavailable properties necessary for maximum absorption.
Mr. Duffield commented, "The CRS hydrodynamic process is able to address the release of select plant phytonutrients to maximize the efficiency of absorption, opening up the multi-billion dollar health and wellness market. By protecting the process of increasing bioavailability with intellectuals, this allows the company to focus on bringing the first botanical products to market -- products that we believe will exhibit demonstrably better benefits than what is currently available to consumers."
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc., through its recent acquisition of Global Energy Solutions, Ltd. and its subsidiaries, focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principal holdings consist of land, farms and infrastructure in South Africa.
Safe Harbor Statement
The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandaí's ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandaí is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.